Related Experiment Video

Updated: Jul 16, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Genetically engineered mouse models of astrocytoma: GEMs in the rough?

K M Reilly1, T Jacks

  • 1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Seminars in Cancer Biology
|June 16, 2001
PubMed

Insights

Developing accurate mouse models for astrocytoma, a common brain cancer, is crucial for understanding its development and testing therapies. Successful models depend on specific genetic changes, cell origins, and mouse strain backgrounds.

Area of Science:

  • Neuro-oncology
  • Cancer biology
  • Genetics

Background:

  • Astrocytomas are the most common and aggressive form of brain cancer.
  • Their diffuse infiltration makes them largely incurable with current therapies.
  • Mouse models are essential for studying astrocytoma development and therapeutic strategies.

Purpose of the Study:

  • To investigate the critical factors influencing the successful development of astrocytoma mouse models.
  • To understand the interplay between genetic alterations, cell type, and genetic background in astrocytoma formation.

Main Methods:

  • Review of existing literature on astrocytoma mouse models.
  • Analysis of genetic alterations, cell-of-origin, and strain backgrounds in successful models.

Main Results:

  • Many mouse models engineered with human astrocytoma mutations fail to replicate the disease.
  • Successful astrocytoma modeling in mice requires a specific combination of molecular alterations.
  • The cell type where mutations occur and the mouse strain background are critical determinants of model fidelity.

Conclusions:

  • The development of reliable astrocytoma mouse models is complex.
  • Optimizing models necessitates careful consideration of genetic mutations, cell type, and host genetic background.
  • Improved mouse models will accelerate the understanding and treatment of human astrocytomas.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures04:01

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...